ReviewDiscover nano2026
Seamless human electronics interfacing through advanced skin attachable and implantable sensor technologies.
Review in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The transition from episodic clinical assessment to continuous physiological monitoring represents a transformative shift in biomedical engineering. This review comprehensively examines recent advancements in human-interfaced sensing systems, categorized into skin-attachable and implantable platforms. We analyze innovations in interface architectures designed to resolve the mechanical mismatch between rigid electronics and soft biological tissues. Key strategies include the utilization of elastomeric substrates, functional hydrogels, and high-performance nanomaterials to ensure mechanical compliance, biocompatibility, and stable electrical contact. Furthermore, this paper details diverse signal measurement modalities, ranging from electrochemical biosensors for metabolic biomarkers (e.g., glucose, lactate) to electrophysiological recordings (ECG, EEG, neural probes) and physical sensing (strain, pressure). Representative applications including smart contact lenses and wireless mouthguards highlight the potential of these technologies in real-world diagnostics. Despite significant progress in wireless telemetry and miniaturization, challenges regarding long-term biostability, enzymatic degradation, and the foreign body response persist. We conclude by discussing the future trajectory toward autonomous, closed-loop theranostic systems integrated with artificial intelligence and biodegradable materials, paving the way for ubiquitous, personalized health management.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.